Home Cart Sign in  
Chemical Structure| 481-72-1 Chemical Structure| 481-72-1

Structure of Aloe emodin
CAS No.: 481-72-1

Chemical Structure| 481-72-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Aloe-emodin, a natural product isolated and purified from the root of Rheum palmatum L. with a specific in vitro and in vivo anti-neuroectodermal tumor activity, reduces the toxicity and ROS induced by both monomeric and oligomeric Aβ species, appears to have some protective effect not only against hepatocyte death but also on the inflammatory response subsequent to lipid peroxidation and has a strong non-carcinogenic stimulant-laxative action when applied to the skin, although it may increase the carcinogenicity of some kind of radiation. Aloe-Emodine dose-dependently inhibited cleavage activity of the 3CLpro with IC50 value of 366μM in the cell-based assay.

Synonyms: Rhabarberone; 3-Hydroxymethylchrysazine; NSC 38628

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Aloe emodin

CAS No. :481-72-1
Formula : C15H10O5
M.W : 270.24
SMILES Code : O=C1C2=C(C=CC=C2O)C(C3=CC(CO)=CC(O)=C13)=O
Synonyms :
Rhabarberone; 3-Hydroxymethylchrysazine; NSC 38628
MDL No. :MFCD00017373
InChI Key :YDQWDHRMZQUTBA-UHFFFAOYSA-N
Pubchem ID :10207

Safety of Aloe emodin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Aloe emodin (Rhabarberone) is a natural hydroxyanthraquinone with antitumor properties, capable of binding to and inhibiting the kinase activity of mTORC2, thus exerting antiproliferative effects and inducing apoptosis in cells[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 cells 0, 50, 100, 200 μM 0, 12, 24, 48, 72 hours To evaluate the inhibitory effect of Aloe emodin on the growth of HepG2 cells. The results showed that AE inhibited the growth of HepG2 cells in a time- and concentration-dependent manner. PMC10600456
Human lung non-small cell carcinoma cell line H460 40 μM 16 hours Investigated Aloe emodin-induced apoptosis, observed nuclear morphological changes and DNA fragmentation. PMC1573035
Human lung squamous carcinoma cell line CH27 40 μM 16 hours Investigated Aloe emodin-induced apoptosis, observed nuclear morphological changes and DNA fragmentation. PMC1573035
SW480 and HT-29 cells 50 μM 16 hours AE only triggered apoptotic cell death in SW480 and HT-29 cells. PMC9157280
HepG2 cells 30 μM 24 hours To evaluate the effect of AE on cholesterol metabolism, it was found that 30 μM AE significantly inhibited SCAP and PCSK9 protein expression, upregulated LDLR expression, and promoted LDL uptake. PMC7470781
H9C2 cells 2 μM 24 hours To investigate the inhibitory effect of Aloe emodin on X-ray-induced mitochondrial dysfunction and mitophagy PMC11653682
HT22 cells 2, 4, 6 μM 24 hours To evaluate the protective effect of Aloe emodin on Aβ25-35-induced AD cell models and its promotion of cell proliferation. Results showed that 6 μM AE significantly increased cell viability and promoted DNA synthesis. PMC11931456
HeLa cells 25 μM and 50 μM 24 hours AE inhibited proliferation and migration and triggered caspase-dependent cell death of HeLa cells in a dose-dependent manner. PMC9157280
HepG2 cells 0, 50, 100, 200 μM 24 hours To evaluate the effect of Aloe emodin on apoptosis of HepG2 cells. The results showed that AE increased the proportion of early and late apoptotic HCC cells in a concentration-dependent manner. PMC10600456
A375 and MCF7 cells 50 μM 24 or 48 hours AE induced the GSDME activation in A375 and MCF7 cells. PMC9157280
ARPE-19 cells 0.2, 1.0 and 5.0 µg/mL 48 hours Inhibits VEGFA secretion in ARPE-19 cells under hypoxia condition PMC5118782
TE-671 medulloblastoma cells 0.14 μg/mL (IC50) 48 hours To evaluate the antiviral activity of aloe-emodin against enterovirus 71 (EV71), showing an IC50 of 0.14 μg/mL. PMC7126984
HL-CZ promonocyte cells 0.52 μg/mL (IC50) 48 hours To evaluate the antiviral activity of aloe-emodin against enterovirus 71 (EV71), showing an IC50 of 0.52 μg/mL. PMC7126984
TE-671 medulloblastoma cells 1.51 μg/mL (IC50) 48 hours To evaluate the antiviral activity of aloe-emodin against Japanese encephalitis virus (JEV), showing an IC50 of 1.51 μg/mL. PMC7126984
HL-CZ promonocyte cells 0.50 μg/mL (IC50) 48 hours To evaluate the antiviral activity of aloe-emodin against Japanese encephalitis virus (JEV), showing an IC50 of 0.50 μg/mL. PMC7126984
HUVEC cells 40, 20, 10 μM 48 hours Evaluate the effects of AE and EMD on HUVEC cells. The results showed that AE and EMD had minimal impact on the survival rate of HUVEC cells, with survival rates exceeding 80%. PMC9694700
MCF-7 cells 40, 20, 10 μM 48 hours Evaluate the effects of AE and EMD on adhesion, invasion, angiogenesis, and anoikis of MCF-7 cells. The results showed that AE and EMD could inhibit adhesion, invasion, and angiogenesis and induce anoikis of MCF-7 cells. PMC9694700
A375 15 μM 48 hours Inhibited cell proliferation, disrupted glycolysis and oxidative phosphorylation, reduced TCA cycle intermediates PMC11990439
COLO 794 15 μM 48 hours Inhibited cell proliferation, disrupted glycolysis and oxidative phosphorylation, reduced TCA cycle intermediates PMC11990439
Mouse lung macrophages (MH-S) 16 µg/ml 5 hours To evaluate the protective effect of Aloe emodin against S. aureus-mediated cell injury. Results showed that Aloe emodin significantly reduced cell death. PMC6530610
Human lung epithelial cells (A549) 16 µg/ml 5 hours To evaluate the protective effect of Aloe emodin against S. aureus-mediated cell injury. Results showed that Aloe emodin significantly reduced cell death. PMC6530610
RAW264.7 cells 300 μM Assess the inhibitory effect of AE on inflammatory cytokines in LPS-stimulated RAW264.7 cells, results showed significant suppression of IL-6, IL-1β, and TNF-α upregulation PMC10418438
RAW264.7 cells 0–300 μM Evaluate the cytotoxicity of AE on RAW264.7 cells, results showed no significant toxicity at 0–300 μmol/L PMC10418438

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice DSS-induced colitis model Intragastric administration 10, 20, 40 mg/kg Once daily for 7 days To evaluate the therapeutic effect of aloe emodin on colitis, results showed that aloe emodin significantly alleviated colitis symptoms and promoted mucosal healing PMC11413701
Wistar rats High-fat diet-induced hyperlipidemia model Intragastric administration 100 mg/kg Once daily for 6 weeks To evaluate the lipid-lowering effect of AE in hyperlipidemic rats, it was found that AE significantly reduced total cholesterol (TC) and low-density lipoprotein (LDL) levels in serum and liver, ameliorated hepatic lipid aggregation, and upregulated LDL receptor expression by inhibiting the PCSK9/LDLR pathway. PMC7470781
Sprague-Dawley rats Radiation-induced heart damage model Intraperitoneal injection 10 mg/kg Once daily for 28 days To evaluate the protective effect of Aloe emodin on radiation-induced heart damage PMC11653682
C57BL/6 mice CLP-induced sepsis model Intraperitoneal injection 0.1, 1.0, and 10 mg/kg Once daily, continuous observation Evaluate the therapeutic effect of AE on CLP-induced sepsis in mice, results showed AE significantly improved survival rate and reduced inflammatory response and organ damage PMC10418438
Sprague-Dawley rats PSD rat model induced by MCAO + CUMS Oral gavage 100 mg/kg Once daily for 21 days AE significantly improved behavioral function, reduced depression levels, improved brain tissue damage and lesions, increased the number of brain tissue neurons, decreased the contents of AQP3, AQP4, AQP5, GFAP, and TRPV4 in the brain and brain tissue, and increased the protein expressions of BDNF and NTF3 in PSprague-Dawley rats. PMC10048947
APP/PS1 double transgenic mice Alzheimer's disease model Intragastric 25, 50, 100 mg/kg Once daily for 28 days To evaluate the effect of Aloe emodin on cognitive dysfunction and hippocampal neuronal damage in AD model mice. Results showed that AE significantly improved cognitive function, reduced hippocampal damage, and activated mitophagy via the AMPK/PGC-1α/SIRT3 pathway. PMC11931456
Guinea pigs T. rubrum-caused tinea corporis model Topical application 10 μM Once daily for three consecutive days Evaluate the therapeutic efficacy of AE-mediated aPDT for T. rubrum-caused tinea corporis. Results showed that after three treatments, skin lesions were significantly improved, and fungal cells on the skin surface were completely inactivated. PMC8867962
C57BL/6J mice S. aureus pneumonia model Hypodermic injection 100 mg/kg Every 8 hours for 72 hours To evaluate the protective effect of Aloe emodin against S. aureus pneumonia. Results showed that Aloe emodin significantly reduced mortality in infected mice and decreased lung inflammation and bacterial colonization. PMC6530610

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.70mL

0.74mL

0.37mL

18.50mL

3.70mL

1.85mL

37.00mL

7.40mL

3.70mL

References

 

Historical Records

Categories